Oscar Health, Inc. (OSCR) stock analysis
OSCR · Oscar Health, Inc.
Latest recorded price: USD 31.33
Model-estimated fair value: USD 62.52. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Healthcare Plans
At $31.33, OSCR trades 49.9% below the model's base-case value of $62.52. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $53.91 in the conservative case and $72.89 in the optimistic case, with a valuation confidence score of 75/100. Fiscal 2025 figures: revenue growth 43.5%, free cash flow margin 9.0%. The model does not flag any risk signals for this company.